TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $223,457 | +80.2% | 18,889 | -9.7% | 0.01% | +57.1% |
| Q3 2022 | $124,000 | -80.1% | 20,914 | -55.9% | 0.01% | -53.3% |
| Q2 2018 | $624,000 | -24.8% | 47,454 | -18.8% | 0.02% | -25.0% |
| Q1 2018 | $830,000 | +55.7% | 58,421 | -10.1% | 0.02% | +66.7% |
| Q4 2017 | $533,000 | +75.3% | 64,957 | +153.1% | 0.01% | +71.4% |
| Q3 2017 | $304,000 | +17.8% | 25,662 | 0.0% | 0.01% | +16.7% |
| Q2 2017 | $258,000 | – | 25,662 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |